on EUROFINS SCIENTIFIC SE (isin : FR0014000MR3)
Eurofins Finalizes Acquisition of Element's Life Sciences Testing Services
On October 1, 2026, Eurofins Scientific, a leader in bioanalytical testing, completed the acquisition of Life Sciences Testing Services from Element Materials Technology in North America. The deal, initially announced on July 20, 2026, was closed for USD 400 million. This strategic move enhances Eurofins' network in key US and Canadian regions.
The acquired business, featuring 27 laboratories and employing 750 staff, provides testing services across Biopharma, Environmental, and Food sectors. It is expected to generate over USD 150 million in annual revenue, aligning with Eurofins' average profitability.
This addition will integrate with Eurofins' existing North American operations, allowing clients broader access to Eurofins' services. CEO Dr. Gilles Martin emphasizes the synergies in their expanded and digitized lab platforms. The transition will ensure consistent service for all customers.
R. P.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all EUROFINS SCIENTIFIC SE news